Bayer Escapes Bulk Of Trasylol Off-Label Marketing Suit
A New Jersey federal judge on Friday cut down a long-running employee whistleblower suit accusing Bayer Corp. of fleecing government health programs by pushing off-label uses of heart-surgery drug Trasylol and...To view the full article, register now.
Already a subscriber? Click here to view full article